Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2010
10/19/2010CA2218251C Coding sequences of the human brca1 gene
10/19/2010CA2193130C New streptogramins and process for preparing streptogramins by mutasynthesis
10/19/2010CA2186118C Compacted nucleic acids and their delivery to cells
10/19/2010CA2178396C Enhancing keratinocyte migration and proliferation with clostridiopeptidase-a-collagenase
10/19/2010CA2177249C Abundant extracellular products and methods for their production and use
10/19/2010CA2165393C Anti-bordetella acellular vaccine
10/19/2010CA2147499C Prostate-specific membrane antigen
10/17/2010CA2701052A1 Method of cancer treatment
10/15/2010WO2009126950A2 Diterpene glycosides as natural solubilizers
10/15/2010CA2758122A1 Diterpene glycosides as natural solubilizers
10/15/2010CA2662650A1 Treatment and prevention of ischemic injury using activated protein c
10/14/2010WO2010118435A2 Par-1 activation by metalloproteinase-1 (mmp-1)
10/14/2010WO2010118424A2 Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines
10/14/2010WO2010118419A2 Novel anti-aging agents and methods to identify them
10/14/2010WO2010118404A2 Methods for creating or identifying compounds that bind tumor necrosis factor alpha
10/14/2010WO2010118384A2 Amylin agonist compounds for estrogen-deficient mammals
10/14/2010WO2010118340A1 Treatment of cutaneous hemangioma
10/14/2010WO2010118259A1 Immunologically active lipopeptides and methods for use thereof
10/14/2010WO2010118241A2 Inhibitors of protein tyrosine phosphatases
10/14/2010WO2010118224A1 Preventing islet inflammation and dysfunction and maintaining proper glucose levels by controlling elf5a and its hypusination
10/14/2010WO2010118169A2 Human protein scaffold with controlled serum pharmacokinetics
10/14/2010WO2010118078A1 Macrocyclic serine protease inhibitors
10/14/2010WO2010118028A1 Method of treating and preventing neuro-olfactory triggered or aggravated illnesses or related conditions
10/14/2010WO2010117997A2 Peptide targeting of inner ear cells
10/14/2010WO2010117957A2 Methods and materials for delivering molecules
10/14/2010WO2010117901A1 Modified dnase compositions and methods of use thereof
10/14/2010WO2010117848A1 Cytokines and neuroantigens for treatment of immune disorders
10/14/2010WO2010117785A1 Leptin antagonist and methods of use
10/14/2010WO2010117727A2 Phenserine and posiphen for treating neuropsychiatric and neurodegenerative conditions
10/14/2010WO2010117079A1 Neuronal differentiation-inducing peptide and use thereof
10/14/2010WO2010117078A1 Neuronal differentiation-inducing peptide and use thereof
10/14/2010WO2010117055A1 Polypeptide having selective inhibitory activity on protein kinase cα or η
10/14/2010WO2010116899A1 Phosphorylation-inhibiting agent or dephosphorylating agent for pten
10/14/2010WO2010116752A1 Neuromedin u derivative
10/14/2010WO2010116375A1 Isolated peptides for regulating apoptosis
10/14/2010WO2010116258A1 Neuron generation, regeneration and protection
10/14/2010WO2010116185A1 Insulin stabilized nanoparticles
10/14/2010WO2010116141A2 Drug combination for the treatment of proteostatic diseases
10/14/2010WO2010116085A1 Cyclic peptides with an anti-parasitic activity
10/14/2010WO2010116016A1 Use of peptides of the e1 protein of the hepatitis g virus in order to inhibit the activity of the hiv virus
10/14/2010WO2010116015A1 Use of peptides of the e2 protein of the hepatitis g virus in order to inhibit the activity of the hiv virus
10/14/2010WO2010115942A1 Caspasin inhibitor peptides
10/14/2010WO2010115932A1 Combination for the treatment of bone loss
10/14/2010WO2010115866A1 Targeted delivery of factor viii proteins to platelets
10/14/2010WO2010115554A1 Combination therapy of an afucosylated antibody and one or more of the cytokines selected from human gm-csf, human m-csf and/or human il-3
10/14/2010WO2010115426A1 Skin care compositions for the delivery of agents
10/14/2010WO2010115318A1 Follicle-stimulating hormone with high specific activity and preparation method thereof
10/14/2010WO2010115230A1 Immunogenic composition and uses thereof
10/14/2010WO2010115229A1 Immunogenic composition and uses thereof
10/14/2010WO2010096188A3 Analogues of neuropeptide y having proline substitution at position 34
10/14/2010WO2010094452A3 Composition comprising n2 - (1-oxohexadecyl) - lysyl - valyl - lysine for treating rosacea and its symptoms
10/14/2010WO2010093627A3 Fibronectin type iii domain based scaffold compositions, methods and uses
10/14/2010WO2010091251A3 Modular triple-helical collagen-like products
10/14/2010WO2010082175A3 Kxk-peptide compositions for cosmetic and dermo-pharmaceutic uses
10/14/2010WO2010077693A3 Method for identifying agents for inhibiting cell motility and invasiveness
10/14/2010WO2010075060A3 Methods and compositions for modulating proline levels
10/14/2010WO2010068907A3 Compositions of proton pump inhibitors and insulin secretagogues, kits and methods of their use to treat diabetes
10/14/2010WO2010068684A3 Methods and compositions for specific modulation of mcl-1
10/14/2010WO2010065613A3 Annexina2 as immunological target
10/14/2010WO2010065085A3 Methods and compositions for treating or preventing pruritis
10/14/2010WO2010062570A3 COMPOSITIONS COMPRISING CAPTURE PEPTIDES FOR A β-AMYLOID PEPTIDE
10/14/2010WO2010056657A3 Low viscosity highly concentrated suspensions
10/14/2010WO2010054187A3 Compositions and methods for regulating sas1r
10/14/2010WO2010042742A3 Chimeric therapeutics, compositions, and methods for using same
10/14/2010WO2010042548A9 Methods of treating inflammation
10/14/2010WO2010020693A3 Enzymes for the treatment of obesity
10/14/2010US20100261880 Ly6h polypeptide
10/14/2010US20100261875 Peptides that specifically bind HGF receptor (CMET) and uses thereof
10/14/2010US20100261874 Synthetic genes for plant gums and other hydroxyproline rich glycoproteins
10/14/2010US20100261872 Factor VIII: remodeling and glycoconjugation of factor VIII
10/14/2010US20100261660 Novel co-stimulatory molecules
10/14/2010US20100261659 Secreted frizzled related protein 3 for use in the inhibition of scarring
10/14/2010US20100261658 Peptide for activating aquaporin synthesis
10/14/2010US20100261657 Use of a Granulin or a Granulin-Like Compound in the Therapy or Prophylaxis of Chronic Pains
10/14/2010US20100261656 Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin
10/14/2010US20100261655 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders
10/14/2010US20100261654 Compositions and methods for increasing vascularization
10/14/2010US20100261653 Polypeptide compounds for inhibiting angiogenesis and tumor growth
10/14/2010US20100261652 Tissue Adhesive Using Engineered Proteins
10/14/2010US20100261651 Purification and Use of a Factor for Supporting Wound Healing
10/14/2010US20100261650 Recombinant fusion proteins to growth hormone and serum albumin
10/14/2010US20100261649 Lh liquid formulations
10/14/2010US20100261648 Use of blood flow parameters to monitor or control the dosing of erythropoiesis-stimulating agents
10/14/2010US20100261647 Fusion proteins for delivery of erythropoietin to the cns
10/14/2010US20100261646 Sustained intraocular delivery of drugs from biodegradable polymeric microparticles
10/14/2010US20100261645 (carboxylalkylenephenyl)phenyloxamides, method for the production thereof and use of same as a medicament
10/14/2010US20100261644 (cyclopropylphenyl)phenyloxamides, method for the production thereof, and use of same as a medicament
10/14/2010US20100261643 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical
10/14/2010US20100261642 Nutritional formulation with high energy content
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010US20100261640 Soluble and membrane anchored forms of lassa virus subunit proteins
10/14/2010US20100261639 Triazole-based aminoglycoside-peptide conjugates and methods of use
10/14/2010US20100261638 Lantibiotic-based compounds having antimicrobial activity
10/14/2010US20100261637 Peptides derivatized with a-b-c-d- and their therapeutical use
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100261200 Glycoprotein VI and Uses Thereof
10/14/2010US20100261194 Neutrokine-alpha antibodies and methods of use thereof
10/14/2010US20100261180 Recombinant perforin, expression and uses thereof
10/14/2010US20100260858 Drug delivery composition
1 ... 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 ... 3163